CD226 and breast cancer: This observation, together with the low fluorescence intensity of DNAM-1, NKp30 and CD16 molecules on NK cells from ASC and ASC-CA groups in relation to the BC group (Figure 2c), indicate down-regulation of important activating receptors, which are known to mediate NK cell antitumor immunity.